{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:19:25Z","timestamp":1790489965824,"version":"4.1.0"},"reference-count":43,"publisher":"BMJ","issue":"3","funder":[{"name":"Austrian Science Funds"},{"DOI":"10.13039\/501100006678","name":"Association Fran\u00e7aise pour l\u2019Etude du Foie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programme PHC Cedre"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Sustained inflammation originating from macrophages is a driving force of fibrosis progression and resolution. Monoacylglycerol lipase (MAGL) is the rate-limiting enzyme in the degradation of monoacylglycerols. It is a proinflammatory enzyme that metabolises 2-arachidonoylglycerol, an endocannabinoid receptor ligand, into arachidonic acid. Here, we investigated the impact of MAGL on inflammation and fibrosis during chronic liver injury.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>C57BL\/6J mice and mice with global invalidation of MAGL (MAGL<jats:bold><jats:sup>-\/-<\/jats:sup><\/jats:bold>), or myeloid-specific deletion of either MAGL (MAGL<jats:sup>Mye-\/-<\/jats:sup>), ATG5 (ATG<jats:sup>Mye-\/-<\/jats:sup>) or CB2 (CB2<jats:sup>Mye-\/-<\/jats:sup>), were used. Fibrosis was induced by repeated carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>) injections or bile duct ligation (BDL). Studies were performed on peritoneal or bone marrow-derived macrophages and Kupffer cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MAGL<jats:bold><jats:sup>-\/-<\/jats:sup><\/jats:bold> or MAGL<jats:sup>Mye-\/-<\/jats:sup> mice exposed to CCl<jats:sub>4<\/jats:sub> or subjected to BDL were more resistant to inflammation and fibrosis than wild-type counterparts. Therapeutic intervention with MJN110, an MAGL inhibitor, reduced hepatic macrophage number and inflammatory gene expression and slowed down fibrosis progression. MAGL inhibitors also accelerated fibrosis regression and increased Ly-6C<jats:sup>low<\/jats:sup> macrophage number. Antifibrogenic effects exclusively relied on MAGL inhibition in macrophages, since MJN110 treatment of MAGL<jats:sup>Mye-\/-<\/jats:sup> BDL mice did not further decrease liver fibrosis. Cultured macrophages exposed to MJN110 or from MAGL<jats:sup>Mye-\/-<\/jats:sup> mice displayed reduced cytokine secretion. These effects were independent of the cannabinoid receptor 2, as they were preserved in CB2<jats:sup>Mye-\/-<\/jats:sup> mice. They relied on macrophage autophagy, since anti-inflammatory and antifibrogenic effects of MJN110 were lost in ATG5<jats:sup>Mye-\/-<\/jats:sup> BDL mice, and were associated with increased autophagic flux and autophagosome biosynthesis in macrophages when MAGL was pharmacologically or genetically inhibited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MAGL is an immunometabolic target in the liver. MAGL inhibitors may show promising antifibrogenic effects during chronic liver injury.<\/jats:p><\/jats:sec>","DOI":"10.1136\/gutjnl-2018-316137","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T16:55:33Z","timestamp":1539104133000},"page":"522-532","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":87,"title":["Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver"],"prefix":"10.1136","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6027-0043","authenticated-orcid":false,"given":"Aida","family":"Habib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Chokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JingHong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Mabire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Ribeiro-Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5372-4585","authenticated-orcid":false,"given":"Maude","family":"Le Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lett\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pilard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellah","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Brouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Tardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Le Faouder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Guillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F","family":"Cravatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lotersztajn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"key":"2020050721341604000_68.3.522.1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.45.120403.095906"},{"key":"2020050721341604000_68.3.522.2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00230.2013"},{"key":"2020050721341604000_68.3.522.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.09.002"},{"key":"2020050721341604000_68.3.522.4","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990344"},{"key":"2020050721341604000_68.3.522.5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2020050721341604000_68.3.522.6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"2020050721341604000_68.3.522.7","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-018-04450-y","article-title":"Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver","volume":"9","author":"Hegde","year":"2018","journal-title":"Nat Commun"},{"key":"2020050721341604000_68.3.522.8","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.11"},{"key":"2020050721341604000_68.3.522.9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27332"},{"key":"2020050721341604000_68.3.522.10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26783"},{"key":"2020050721341604000_68.3.522.11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200522675"},{"key":"2020050721341604000_68.3.522.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119964109"},{"key":"2020050721341604000_68.3.522.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.12.018"},{"key":"2020050721341604000_68.3.522.14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.152334899"},{"key":"2020050721341604000_68.3.522.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.12.050"},{"key":"2020050721341604000_68.3.522.16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24524"},{"key":"2020050721341604000_68.3.522.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.032"},{"key":"2020050721341604000_68.3.522.18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23779"},{"key":"2020050721341604000_68.3.522.19","doi-asserted-by":"publisher","DOI":"10.1038\/nm1421"},{"key":"2020050721341604000_68.3.522.20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1209200"},{"key":"2020050721341604000_68.3.522.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2014.03.001"},{"key":"2020050721341604000_68.3.522.22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2017.02.033","article-title":"Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling","volume":"175","author":"Grabner","year":"2017","journal-title":"Pharmacol Ther"},{"key":"2020050721341604000_68.3.522.23","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2616"},{"key":"2020050721341604000_68.3.522.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.06.075"},{"key":"2020050721341604000_68.3.522.25","doi-asserted-by":"publisher","DOI":"10.1038\/srep28806"},{"key":"2020050721341604000_68.3.522.26","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2015.1058473"},{"key":"2020050721341604000_68.3.522.27","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.129"},{"key":"2020050721341604000_68.3.522.28","doi-asserted-by":"publisher","DOI":"10.1021\/cn400116z"},{"key":"2020050721341604000_68.3.522.29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.12.028"},{"key":"2020050721341604000_68.3.522.30","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3389\/fimmu.2017.01214","article-title":"Cannabinoid Receptor 1 Participates in Liver Inflammation by Promoting M1 Macrophage Polarization via RhoA\/NF-\u03baB p65 and ERK1\/2 Pathways, Respectively, in Mouse Liver Fibrogenesis","volume":"8","author":"Tian","year":"2017","journal-title":"Front Immunol"},{"key":"2020050721341604000_68.3.522.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1314017110"},{"key":"2020050721341604000_68.3.522.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.07.009"},{"key":"2020050721341604000_68.3.522.33","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-176602"},{"key":"2020050721341604000_68.3.522.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.10.109"},{"key":"2020050721341604000_68.3.522.35","doi-asserted-by":"crossref","unstructured":"Costola-de-Souza C , Ribeiro A , Ferraz-de-Paula V , et al . Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice. PLoS One 2013;8:e77706.doi:10.1371\/journal.pone.0077706","DOI":"10.1371\/journal.pone.0077706"},{"key":"2020050721341604000_68.3.522.36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2015.04.018","article-title":"The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats","volume":"761","author":"Jiang","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"2020050721341604000_68.3.522.37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.215434"},{"key":"2020050721341604000_68.3.522.38","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1038\/s41467-018-04999-8","article-title":"Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression","volume":"9","author":"Xiang","year":"2018","journal-title":"Nat Commun"},{"key":"2020050721341604000_68.3.522.39","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201426"},{"key":"2020050721341604000_68.3.522.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.06.075"},{"key":"2020050721341604000_68.3.522.41","doi-asserted-by":"crossref","unstructured":"Sanchez-Alavez M , Nguyen W , Mori S , et al . Monoacylglycerol Lipase Regulates Fever Response. PLoS One 2015;10:e0134437.doi:10.1371\/journal.pone.0134437","DOI":"10.1371\/journal.pone.0134437"},{"key":"2020050721341604000_68.3.522.42","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1007\/s12035-017-0689-x","article-title":"Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors","volume":"55","author":"Zhang","year":"2018","journal-title":"Mol Neurobiol"},{"key":"2020050721341604000_68.3.522.43","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00295.2016"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2018-316137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:04:29Z","timestamp":1601053469000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2018-316137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2,7]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/gutjnl-2018-316137"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2018-316137","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,9]]}}}